With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Investigating the role of lin-28 in germ cell tumorigenesis||Boston Children’s Hospital / George Daley||Innovation Grants||2009||Massachusetts|
|Development of RADARS-based Therapy to Treat Fusion Molecule Driven Pediatric Malignancies||Boston Children’s Hospital / Alan B. Cantor, MD, PhD||Innovation Grants||2023||Massachusetts|
|Investigating the Role of Lin-28 in Germ Cell Tumorigenesis||Boston Children’s Hospital / George Daley, MD/PhD||Innovation Grants||2011||Massachusetts|
|Barcoding Pediatric Leukemia for Therapeutic Purposes||Boston Children’s Hospital / Leonard Zon, MD||Crazy 8 Awards||2020||Massachusetts|
|Targeting the Rac GTPase Pathway to Sabotage RAS Signaling in RAS-mutated Leukemia||Boston Children’s Hospital / Sara Canovas Nunes, PhD||Young Investigator Grants||2020||Massachusetts|
|GeneEditing in T cell Leukemia to Promote Immunomodulatory Forms of Cell Death||Boston Children’s Hospital / Dr. Ben Croker, PhD||Innovation Grants||2016||Massachusetts|
|Targeted Inhibition of Lin28/let-7 Binding to Treat Pediatric Malignancy||Boston Children’s Hospital / George Q. Daley, MD/PhD||Innovation Grants||2016||Massachusetts|
|Selective Epigenetic Regulation of Notch1 in T-cell Acute Lymphoblastic Leukemia||University of Michigan / Mark Yat-Fung Chiang, MD/PhD||Innovation Grants||2016||Michigan|
|Therapeutic Targeting of the Disrupted Metabolic State in DIPG||University of Michigan / Costas Lyssiotis, PhD & Sriram Venneti, MD/PhD||Innovation Grants||2019||Michigan|
|Engager T Cells: A Novel Immunotherapeutic for AML||University of Michigan / Challice Bonifant, MD, PhD||Young Investigator Grants||2015||Michigan|